Recruiting
Phase 1
Phase 2

BGB-11417

Sponsor:

BeOne Medicines

Code:

NCT04771130

Conditions

Acute Myeloid Leukemia

Myelodysplastic Syndromes

Myelodysplastic/Myeloproliferative Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BGB-11417

Azacitidine

Posaconazole

BGB-11417

BGB-11417

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-12. This information was provided to ClinicalTrials.gov by BeOne Medicines on 2026-07-13.